
Comprehend Systems, a clinical software solutions provider, announced the launch of Continuous Quality for ClinOps.

Comprehend Systems, a clinical software solutions provider, announced the launch of Continuous Quality for ClinOps.


ArisGlobal, a provider of cloud solutions to life sciences companies, announced it has acquired Medsight Solutions, which includes its integrated risk management solution, Medsight Sapphire.



ERT, a global provider of patient safety and efficacy endpoint data collection, cloud analytics and workflow solutions, announced that MasterScope® 2, its comprehensive diagnostic platform for spirometry, electrocardiogram (ECG) and home monitoring, has been successfully implemented with 350 investigative sites.

ArisGlobal, a provider of cloud solutions to life sciences companies, announced agReporter a solution for users to correspond with drug manufacturers and get the latest medical advice.


Version 3.0 of the TMF Reference Model incorporates feedback from its extensive industry use to enhance content clarity.


New portal solution allows investigators to access, sign, and upload eTMF documents on site.


Double-blind randomized controlled trials of new drugs may fail to measure how a medication’s performance can vary based on patients' lifestyle choices, especially if patients change their habits because they are anticipating treatment, according to a new study published in Plos One.



Comprehensive behavioral and performance data on over 40,000 investigator sites

Participate sets a new standard for usability, integration, and cost effectiveness for electronic patient reported outcomes (ePRO).


PatientsLikeMe and the FDA have signed a research collaboration agreement to determine how patient-reported data can give new insights into drug safety.

UK-based Medical Research Network (MRN) has entered into a strategic partnership with World Courier to create a more highly integrated model for community-based clinical trials.

In the U.S. alone, around $28 billion a year is spent on preclinical research that is not reproducible, and low reproducibility rates contribute to both delays and costs of therapeutic drug development.



The Society for Clinical Research Sites (SCRS), a global trade organization dedicated to the interests of clinical research sites, announced a two-year partnership with Bristol-Myers Squibb.

INC Research formally launched the first Site Advocacy Group (SAG), initially focused on central nervous system (CNS) protocols.


The Society for Clinical Research Sites (SCRS), a global trade organization representing the interests of clinical research sites, announced a two-year relationship with Center Point Clinical Services.

Challenging. Time-consuming. Expensive. Do words like these spring to mind when you contemplate the patient recruitment process for your clinical trials?
